Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:2848-2855
Published online before print May 21, 2007, doi: 10.1161/CIRCULATIONAHA.106.654210
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
115/22/2848    most recent
CIRCULATIONAHA.106.654210v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergler-Klein, J.
Right arrow Articles by Baumgartner, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergler-Klein, J.
Right arrow Articles by Baumgartner, H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Other heart failure
Right arrow Valvular heart disease
Right arrow CV surgery: valvular disease

(Circulation. 2007;115:2848-2855.)
© 2007 American Heart Association, Inc.


Valvular Heart Disease

B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis

Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study

Jutta Bergler-Klein, MD; Gerald Mundigler, MD; Philippe Pibarot, DVM, PhD; Ian G. Burwash, MD; Jean G. Dumesnil, MD; Claudia Blais, MSc; Christina Fuchs, MD; Dania Mohty, MD, MSc; Rob S. Beanlands, MD; Zeineb Hachicha, MD; Nicole Walter-Publig, MD; Florian Rader, MD; Helmut Baumgartner, MD

From the Department of Cardiology (J.B.-K., G.M., C.F., N.W.-P., F.R., H.B.), Medical University of Vienna, Vienna, Austria; Laval Hospital/Quebec Heart Institute (P.P., J.G.D., C.B., D.M., Z.H.), Laval University, Sainte-Foy, Quebec, Canada; and the University of Ottawa Heart Institute (I.G.B, R.S.B), Ottawa, Ontario, Canada.

Correspondence to Jutta Bergler-Klein, MD, Department of Cardiology, Medical University of Vienna, Waehringer-Guertel 18-20, A-1090 Vienna, Austria. E-mail jutta.bergler-klein{at}meduniwien.ac.at

Received August 11, 2006; accepted March 19, 2007.

Background— The prognostic value of B-type natriuretic peptide (BNP) is unknown in low-flow, low-gradient aortic stenosis (AS). We sought to evaluate the relationship between AS and rest, stress hemodynamics, and clinical outcome.

Methods and Results— BNP was measured in 69 patients with low-flow AS (indexed effective orifice area <0.6 cm2/m2, mean gradient ≤40 mm Hg, left ventricular ejection fraction ≤40%). All patients underwent dobutamine stress echocardiography and were classified as truly severe or pseudosevere AS by their projected effective orifice area at normal flow rate of 250 mL/s (effective orifice area ≤1.0 cm2 or >1.0 cm2). BNP was inversely related to ejection fraction at rest (Spearman correlation coefficient rs=–0.59, P<0.0001) and at peak stress (rs=–0.51, P<0.0001), effective orifice area at rest (rs=–0.50, P<0.0001) and at peak stress (rs=–0.46, P=0.0002), and mean transvalvular flow (rs=–0.31, P=0.01). BNP was directly related to valvular resistance (rs=0.42, P=0.0006) and wall motion score index (rs=0.36, P=0.004). BNP was higher in 29 patients with truly severe AS versus 40 with pseudosevere AS (median, 743 pg/mL [Q1, 471; Q3, 1356] versus 394 pg/mL [Q1, 191 to Q3, 906], P=0.012). BNP was a strong predictor of outcome. In the total cohort, cumulative 1-year survival of patients with BNP ≥550 pg/mL was only 47±9% versus 97±3% with BNP <550 (P<0.0001). In 29 patients who underwent valve replacement, postoperative 1-year survival was also markedly lower in patients with BNP ≥550 pg/mL (53±13% versus 92±7%).

Conclusions— BNP is significantly higher in truly severe than pseudosevere low-gradient AS and predicts survival of the whole cohort and in patients undergoing valve replacement.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
P. Lancellotti, C. Szymanski, M. Moonen, C. Garweg, K. O'Connor, C. Tribouilloy, and L. A. Pierard
Dynamic left ventricular dyssynchrony: a potential cause of no contractile reserve in patients with low-gradient aortic stenosis
Eur J Echocardiogr, October 1, 2009; 10(7): 880 - 883.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Weidemann, S. Herrmann, S. Stork, M. Niemann, S. Frantz, V. Lange, M. Beer, S. Gattenlohner, W. Voelker, G. Ertl, et al.
Impact of Myocardial Fibrosis in Patients With Symptomatic Severe Aortic Stenosis
Circulation, August 18, 2009; 120(7): 577 - 584.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. E. Coglianese and R. Davidoff
Predicting Outcome in Patients With Asymptomatic Aortic Stenosis
Circulation, July 7, 2009; 120(1): 9 - 11.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. Tribouilloy, F. Levy, D. Rusinaru, P. Gueret, H. Petit-Eisenmann, S. Baleynaud, Y. Jobic, C. Adams, B. Lelong, A. Pasquet, et al.
Outcome After Aortic Valve Replacement for Low-Flow/Low-Gradient Aortic Stenosis Without Contractile Reserve on Dobutamine Stress Echocardiography
J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1865 - 1873.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
R. W. Troughton and A. M. Richards
B-type natriuretic peptides and echocardiographic measures of cardiac structure and function.
J. Am. Coll. Cardiol. Img., February 1, 2009; 2(2): 216 - 225.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C. Tribouilloy and F. Levy
Assessment and management of low-gradient, low ejection fraction aortic stenosis
Heart, December 1, 2008; 94(12): 1526 - 1527.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. P. Dal-Bianco, B. K. Khandheria, F. Mookadam, F. Gentile, and P. P. Sengupta
Management of Asymptomatic Severe Aortic Stenosis
J. Am. Coll. Cardiol., October 14, 2008; 52(16): 1279 - 1292.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M.-A. Clavel, C. Fuchs, I. G. Burwash, G. Mundigler, J. G. Dumesnil, H. Baumgartner, J. Bergler-Klein, R. S. Beanlands, P. Mathieu, J. Magne, et al.
Predictors of Outcomes in Low-Flow, Low-Gradient Aortic Stenosis: Results of the Multicenter TOPAS Study
Circulation, September 30, 2008; 118(14_suppl_1): S234 - S242.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
H. Subramanian, B. Kunadian, and J. Dunning
Is it ever worth contemplating an aortic valve replacement on patients with low gradient severe aortic stenosis but poor left ventricular function with no contractile reserve?
Interactive CardioVascular and Thoracic Surgery, April 1, 2008; 7(2): 301 - 305.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Carabello
Aortic Stenosis: Two Steps Forward, One Step Back
Circulation, June 5, 2007; 115(22): 2799 - 2800.
[Full Text] [PDF]